<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="17968">Butyrate</z:chebi>, an intestinal microbiota metabolite of dietary fiber, has been shown to exhibit protective effects toward <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> such as <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC) and <z:mp ids='MP_0001845'>inflammation</z:mp>-mediated <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have shown that <z:hpo ids='HP_0011010'>chronic</z:hpo> IFN-γ signaling plays an essential role in <z:mp ids='MP_0001845'>inflammation</z:mp>-mediated <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> development in vivo, whereas genome-wide association studies have linked human UC risk loci to IFNG, the gene that encodes IFN-γ </plain></SENT>
<SENT sid="2" pm="."><plain>However, the molecular mechanisms underlying the <z:chebi fb="0" ids="17968">butyrate</z:chebi>-IFN-γ-colonic <z:mp ids='MP_0001845'>inflammation</z:mp> axis are not well defined </plain></SENT>
<SENT sid="3" pm="."><plain>Here we showed that colonic mucosa from patients with UC exhibit increased signal transducer and activator of transcription 1 (STAT1) activation, and this STAT1 hyperactivation is correlated with increased T cell infiltration </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="17968">Butyrate</z:chebi> treatment-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:mp ids='MP_0002169'>wild-type</z:mp> T cells but not Fas-deficient (Fas(lpr)) or FasL-deficient (Fas(gld)) T cells, revealing a potential role of Fas-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of T cells as a mechanism of <z:chebi fb="0" ids="17968">butyrate</z:chebi> function </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="15358">Histone</z:chebi> deacetylase 1 (HDAC1) was found to bind to the Fas promoter in T cells, and <z:chebi fb="0" ids="17968">butyrate</z:chebi> inhibits HDAC1 activity to induce Fas promoter hyperacetylation and Fas upregulation in T cells </plain></SENT>
<SENT sid="6" pm="."><plain>Knocking down gpr109a or slc5a8, the genes that encode for receptor and transporter of <z:chebi fb="0" ids="17968">butyrate</z:chebi>, respectively, resulted in altered expression of genes related to multiple inflammatory signaling pathways, including inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS), in mouse colonic epithelial cells in vivo </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="17968">Butyrate</z:chebi> effectively inhibited IFN-γ-induced STAT1 activation, resulting in inhibition of iNOS upregulation in human colon epithelial and <z:mp ids='MP_0002038'>carcinoma</z:mp> cells in vitro </plain></SENT>
<SENT sid="8" pm="."><plain>Our data thus suggest that <z:chebi fb="0" ids="17968">butyrate</z:chebi> delivers a double-hit: induction of T cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> to eliminate the source of <z:mp ids='MP_0001845'>inflammation</z:mp> and suppression of IFN-γ-mediated <z:mp ids='MP_0001845'>inflammation</z:mp> in colonic epithelial cells, to suppress colonic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
</text></document>